Metabolomics Services Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

Description

Metabolomics Services Market size was valued at USD 111.5 million in 2021, growing at a CAGR of 12.5% over 2022-2028. The study and analysis of biochemical processes including metabolic intermediates and byproducts are known as metabolomics. Metabolomes are a phrase used to describe a collection of all metabolites engaged in various processes in an organism, including metabolic intermediates, signaling molecules, secondary metabolites, and hormones. By product segment, the largest market for metabolomics is metabolomics bioinformatics services and the segment is expected to expand at the highest CAGR throughout the projected period due to a large number of users of metabolomics analysis tools and services and the increasing need for data management. Moreover, players are focusing on acquisition for better growth in the market. For instance, in 2020, Danaher Corporation entered into a definitive agreement with General Electric Company to acquire the Biopharma business of GE Life Sciences. Some of the major factors that will likely accelerate the growth of the metabolomics services market in the projected timeframe are an increase in the number of patients suffering from neurological disorders, cancer, and cardiac diseases, increasing growth of the healthcare industry across the globe, increasing demand for personalized medicine, and an increase in the need for accurate disease diagnosis.

Recent Market Developments:

In July 2021, Thermo Fisher Scientific, Inc. and the University of California, Davis (UC Davis) launched the Center of Excellence in Clinical Metabolomics, a research collaboration to provide innovations, best practices, and standard operating procedures to the metabolomics community.